Cavitation Technologies, Inc. financial data

Symbol
CVAT on OTC
Location
10019 Canoga Avenue, Chatsworth,, CA
Fiscal year end
June 30
Former names
Bioenergy Inc. (to 11/6/2008)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.3 % -44.5%
Quick Ratio 4.7 % +176%
Debt-to-equity -122 % +74.8%
Return On Assets 266 %
Operating Margin 33.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 284M shares 0%
Common Stock, Shares, Outstanding 284M shares 0%
Entity Public Float 5.47M USD +1.46%
Common Stock, Value, Issued 284K USD 0%
Weighted Average Number of Shares Outstanding, Basic 284M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 284M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.36M USD +692%
Cost of Revenue 156K USD +28.9%
Research and Development Expense 33K USD -15.4%
General and Administrative Expense 712K USD -37.8%
Operating Income (Loss) 462K USD +9.6%
Nonoperating Income (Expense) -19K USD -119%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 331K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 463K USD +9.56%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2K USD -98.6%
Accounts Receivable, after Allowance for Credit Loss, Current 19K USD
Inventory, Net 0 USD -100%
Assets, Current 42K USD -70%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 24K USD -74.7%
Assets 77K USD -68.8%
Employee-related Liabilities, Current 433K USD +32.8%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 656K USD -47%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 784K USD -44.7%
Retained Earnings (Accumulated Deficit) -27.1M USD +1.68%
Stockholders' Equity Attributable to Parent -707K USD +39.6%
Liabilities and Equity 77K USD -68.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -175K USD -243%
Net Cash Provided by (Used in) Financing Activities -2K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 284M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2K USD -98.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD -50%
Deferred Tax Assets, Valuation Allowance 3.93M USD -12%
Deferred Tax Assets, Gross 3.93M USD -12%
Operating Lease, Liability 27K USD -73.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 47K USD
Property, Plant and Equipment, Gross 524K USD 0%
Operating Lease, Liability, Current 27K USD -60.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 53K USD -32.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 47K USD -39.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 78K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 2.97M USD -15.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 53K USD +12.8%
Additional Paid in Capital 26.1M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense -1K USD -117%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%